469 related articles for article (PubMed ID: 28809565)
1. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
Zhang J; Wang S; Wei Q; Guo Q; Bai Y; Yang S; Song F; Zhang L; Lei X
Bioorg Med Chem; 2017 Oct; 25(19):5133-5141. PubMed ID: 28784300
[TBL] [Abstract][Full Text] [Related]
3. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.
Chen AY; Thomas PW; Cheng Z; Xu NY; Tierney DL; Crowder MW; Fast W; Cohen SM
ChemMedChem; 2019 Jul; 14(13):1271-1282. PubMed ID: 31124602
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning Models Identify Inhibitors of New Delhi Metallo-β-lactamase.
Cheng Z; Aitha M; Thomas CA; Sturgill A; Fairweather M; Hu A; Bethel CR; Rivera DD; Dranchak P; Thomas PW; Li H; Feng Q; Tao K; Song M; Sun N; Wang S; Silwal SB; Page RC; Fast W; Bonomo RA; Weese M; Martinez W; Inglese J; Crowder MW
J Chem Inf Model; 2024 May; 64(10):3977-3991. PubMed ID: 38727192
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
[TBL] [Abstract][Full Text] [Related]
7. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada.
Mulvey MR; Grant JM; Plewes K; Roscoe D; Boyd DA
Emerg Infect Dis; 2011 Jan; 17(1):103-6. PubMed ID: 21192866
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
[TBL] [Abstract][Full Text] [Related]
9. Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.
van Haren MJ; Tehrani KHME; Kotsogianni I; Wade N; Brüchle NC; Mashayekhi V; Martin NI
Chemistry; 2021 Feb; 27(11):3806-3811. PubMed ID: 33237604
[TBL] [Abstract][Full Text] [Related]
10. The present danger of New Delhi metallo-β-lactamase: a threat to public health.
Qamar MU; Lopes BS; Hassan B; Khurshid M; Shafique M; Atif Nisar M; Mohsin M; Nawaz Z; Muzammil S; Aslam B; Ejaz H; Toleman MA
Future Microbiol; 2020 Dec; 15(18):1759-1778. PubMed ID: 33404261
[TBL] [Abstract][Full Text] [Related]
11. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases.
Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S
Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Yong D; Toleman MA; Giske CG; Cho HS; Sundman K; Lee K; Walsh TR
Antimicrob Agents Chemother; 2009 Dec; 53(12):5046-54. PubMed ID: 19770275
[TBL] [Abstract][Full Text] [Related]
14. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
16. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
[TBL] [Abstract][Full Text] [Related]
17. Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.
MacVane SH; Crandon JL; Nichols WW; Nicolau DP
Antimicrob Agents Chemother; 2014 Nov; 58(11):7007-9. PubMed ID: 25223998
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
[TBL] [Abstract][Full Text] [Related]
19. Recent research and development of NDM-1 inhibitors.
Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
Ma B; Fang C; Lu L; Wang M; Xue X; Zhou Y; Li M; Hu Y; Luo X; Hou Z
Nat Commun; 2019 Aug; 10(1):3517. PubMed ID: 31388008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
